Beta Bionics (BBNX) Enterprise Value (2023 - 2026)

Beta Bionics has disclosed Enterprise Value across 4 years of filings, most recently posting -$30.3 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$30.3 million, up 86.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$30.3 million (up 86.91% YoY), and the FY2025 annual result was -$219.1 million, down 111.56% from the prior year.
• Enterprise Value came in at -$30.3 million for Q1 2026 at Beta Bionics, up from -$219.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$13.0 million in Q2 2024 to a low of -$249.7 million in Q2 2025.
• The 4-year median for Enterprise Value is -$100.2 million (2023), against an average of -$121.2 million.
• Across the five-year window, Enterprise Value slumped 1816.65% in 2025 and soared 86.91% in 2026, its largest moves.
• Beta Bionics' Enterprise Value stood at -$96.7 million in 2023, then retreated by 7.06% to -$103.6 million in 2024, then plunged by 111.56% to -$219.1 million in 2025, then jumped by 86.17% to -$30.3 million in 2026.
• The last three Enterprise Value figures came in at -$30.3 million (Q1 2026), -$219.1 million (Q4 2025), and -$228.7 million (Q3 2025), per Business Quant data.